Sintx Technologies (NASDAQ:SINT – Get Rating) and SANUWAVE Health (OTCMKTS:SNWV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.
Analyst Ratings
This is a breakdown of current ratings and price targets for Sintx Technologies and SANUWAVE Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 0 | 0 | 1 | 0 | 3.00 |
| SANUWAVE Health | 0 | 0 | 0 | 0 | N/A |
Sintx Technologies currently has a consensus target price of $2.75, suggesting a potential upside of 455.56%. Given Sintx Technologies’ higher possible upside, equities analysts clearly believe Sintx Technologies is more favorable than SANUWAVE Health.
Profitability
This table compares Sintx Technologies and SANUWAVE Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -1,596.24% | -39.53% | -32.27% |
| SANUWAVE Health | -262.90% | N/A | -143.35% |
Volatility and Risk
Sintx Technologies has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, SANUWAVE Health has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500.
Earnings & Valuation
This table compares Sintx Technologies and SANUWAVE Health’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $590,000.00 | 20.73 | -$7.03 million | N/A | N/A |
| SANUWAVE Health | $4.06 million | 20.38 | -$30.94 million | N/A | N/A |
Sintx Technologies has higher earnings, but lower revenue than SANUWAVE Health.
Institutional & Insider Ownership
7.2% of Sintx Technologies shares are owned by institutional investors. Comparatively, 6.5% of SANUWAVE Health shares are owned by institutional investors. 0.8% of Sintx Technologies shares are owned by company insiders. Comparatively, 9.7% of SANUWAVE Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Sintx Technologies beats SANUWAVE Health on 7 of the 11 factors compared between the two stocks.
Sintx Technologies Company Profile (Get Rating)
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.
SANUWAVE Health Company Profile (Get Rating)
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Suwanee, GA.
Want More Great Investing Ideas?
Receive News & Ratings for Sintx Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sintx Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
